Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
Charlene M. Dawidczyk, Luisa M. Russell, Peter C. Searson
Frontiers in Chemistry (2014) Vol. 2
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
George Mattheolabakis, Lara Milane, Amit Singh, et al.
Journal of drug targeting (2015) Vol. 23, Iss. 7-8, pp. 605-618
Closed Access | Times Cited: 497
Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges
Hong Wen, Huijeong Jung, Xuhong Li
The AAPS Journal (2015) Vol. 17, Iss. 6, pp. 1327-1340
Open Access | Times Cited: 488
Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics
Young Hee Choi, Hyo‐Kyung Han
Journal of Pharmaceutical Investigation (2017) Vol. 48, Iss. 1, pp. 43-60
Open Access | Times Cited: 371
Bridging Bio–Nano Science and Cancer Nanomedicine
Mattias Björnmalm, Kristofer J. Thurecht, Michael Michael, et al.
ACS Nano (2017) Vol. 11, Iss. 10, pp. 9594-9613
Open Access | Times Cited: 353
Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells
Yan Liu, Pengcheng Zhang, Feifei Li, et al.
Theranostics (2018) Vol. 8, Iss. 7, pp. 1824-1849
Open Access | Times Cited: 281
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology
Edward A. Sykes, Qin Dai, Christopher D. Sarsons, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 9
Open Access | Times Cited: 261
Design considerations for nanotherapeutics in oncology
Triantafyllos Stylianopoulos, Rakesh K. Jain
Nanomedicine Nanotechnology Biology and Medicine (2015) Vol. 11, Iss. 8, pp. 1893-1907
Open Access | Times Cited: 241
Mediating Passive Tumor Accumulation through Particle Size, Tumor Type, and Location
Jillian L. Perry, Kevin Reuter, J. Christopher Luft, et al.
Nano Letters (2017) Vol. 17, Iss. 5, pp. 2879-2886
Open Access | Times Cited: 235
Recent advances in "smart" delivery systems for extended drug release in cancer therapy
Regina-Veronicka Kalaydina, Komal Bajwa, Bessi Qorri, et al.
International Journal of Nanomedicine (2018) Vol. Volume 13, pp. 4727-4745
Open Access | Times Cited: 218
The “Sweet” Side of the Protein Corona: Effects of Glycosylation on Nanoparticle–Cell Interactions
Sha Wan, Philip M. Kelly, Eugene Mahon, et al.
ACS Nano (2015) Vol. 9, Iss. 2, pp. 2157-2166
Open Access | Times Cited: 201
Recent advances in the modification of carbon-based quantum dots for biomedical applications
Amirhossein Alaghmandfard, Omid Sedighi, Nima Tabatabaei Rezaei, et al.
Materials Science and Engineering C (2020) Vol. 120, pp. 111756-111756
Open Access | Times Cited: 173
Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles
Larissa Pereira Brumano, Francisco Vitor Santos da Silva, Tales A. Costa-Silva, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 6
Open Access | Times Cited: 164
Stealth nanoparticles in oncology: Facing the PEG dilemma
Sara Zalba, Timo L.M. ten Hagen, Carmen Burgui, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 22-36
Closed Access | Times Cited: 150
Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials
Natalia Krasteva, Milena Georgieva
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1213-1213
Open Access | Times Cited: 85
Effects of nanoparticle size, shape, and zeta potential on drug delivery
Kıvılcım Öztürk, Meryem Kaplan, Sema Çalış
International Journal of Pharmaceutics (2024), pp. 124799-124799
Closed Access | Times Cited: 50
Engineering and surface modification of carbon quantum dots for cancer bioimaging
Hussein Riyadh Abdul Kareem Al‐Hetty, Abduladheem Turki Jalil, Jabbar Hassoon Zamil Al-Tamimi, et al.
Inorganic Chemistry Communications (2023) Vol. 149, pp. 110433-110433
Closed Access | Times Cited: 46
Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges
Alexander Komin, Luisa M. Russell, K.A. Hristova, et al.
Advanced Drug Delivery Reviews (2016) Vol. 110-111, pp. 52-64
Closed Access | Times Cited: 167
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel, Katarzyna Niemirowicz, Marzena Wątek, et al.
Journal of Nanobiotechnology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 158
Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives
Thavasyappan Thambi, Jae Hyung Park, Doo Sung Lee
Chemical Communications (2016) Vol. 52, Iss. 55, pp. 8492-8500
Closed Access | Times Cited: 148
Serum protein-based nanoparticles for cancer diagnosis and treatment
Haroon Iqbal, Tao Yang, Ting Li, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 997-1022
Closed Access | Times Cited: 130
Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex
Ting Kang, Mengyin Jiang, Di Jiang, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 8, pp. 2947-2961
Closed Access | Times Cited: 126
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma
Kyle T. Householder, Danielle M. DiPerna, Eugene P. Chung, et al.
International Journal of Pharmaceutics (2015) Vol. 479, Iss. 2, pp. 374-380
Open Access | Times Cited: 124
Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
So Yun Lee, Moon Sung Kang, Woo Yeup Jeong, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 940-940
Open Access | Times Cited: 123
Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect
Andrew D. Wong, Mao Ye, Martin B. Ulmschneider, et al.
PLoS ONE (2015) Vol. 10, Iss. 5, pp. e0123461-e0123461
Open Access | Times Cited: 121
Nanocarriers for microRNA delivery in cancer medicine
I. Fernandez-Piñeiro, Iker Badiola, Alejandro Sánchez
Biotechnology Advances (2017) Vol. 35, Iss. 3, pp. 350-360
Closed Access | Times Cited: 108
Page 1 - Next Page

Scroll to top